A detailed history of Citigroup Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Citigroup Inc holds 41,170 shares of CDNA stock, worth $881,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,170
Previous 32,375 27.17%
Holding current value
$881,861
Previous $502,000 155.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.41 - $33.99 $126,735 - $298,942
8,795 Added 27.17%
41,170 $1.29 Million
Q2 2024

Aug 12, 2024

SELL
$7.56 - $16.15 $2.72 Million - $5.81 Million
-359,446 Reduced 91.74%
32,375 $502,000
Q1 2024

May 10, 2024

BUY
$7.96 - $12.37 $2.46 Million - $3.82 Million
309,084 Added 373.57%
391,821 $4.15 Million
Q4 2023

Feb 09, 2024

SELL
$4.9 - $12.86 $244,132 - $640,723
-49,823 Reduced 37.59%
82,737 $992,000
Q3 2023

Nov 09, 2023

BUY
$7.0 - $11.26 $61,376 - $98,727
8,768 Added 7.08%
132,560 $927,000
Q2 2023

Aug 10, 2023

SELL
$7.61 - $9.46 $1.56 Million - $1.94 Million
-204,771 Reduced 62.32%
123,792 $1.05 Million
Q1 2023

May 11, 2023

BUY
$8.83 - $17.61 $960,783 - $1.92 Million
108,809 Added 49.51%
328,563 $3 Million
Q4 2022

Feb 09, 2023

SELL
$10.88 - $20.05 $552,867 - $1.02 Million
-50,815 Reduced 18.78%
219,754 $2.51 Million
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $1.45 Million - $2.39 Million
90,455 Added 50.22%
270,569 $4.61 Million
Q2 2022

Aug 10, 2022

BUY
$20.49 - $39.72 $2.82 Million - $5.46 Million
137,558 Added 323.24%
180,114 $3.87 Million
Q1 2022

May 12, 2022

SELL
$28.19 - $46.6 $2.08 Million - $3.44 Million
-73,740 Reduced 63.41%
42,556 $1.58 Million
Q4 2021

Feb 10, 2022

BUY
$41.2 - $73.6 $2.76 Million - $4.94 Million
67,057 Added 136.19%
116,296 $5.29 Million
Q3 2021

Nov 10, 2021

BUY
$59.15 - $91.99 $2.91 Million - $4.53 Million
49,239 New
49,239 $3.12 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.